Alicia C Marín

Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c−CCR2−CX3CR1− counterparts, are expanded in inflammatory bowel disease

David Bernardo, Alicia C Marín, Samuel Fernández‐Tomé et al. · Mucosal Immunology · 2018 · 150 citations · Full text

Life Sciences, Immunology, Pathology +17

Randomised clinical trial comparing sequential and concomitant therapies for <i>Helicobacter pylori</i> eradication in routine clinical practice

Adrián G. McNicholl, Alicia C Marín, Javier Molina‐Infante et al. · Gut · 2013 · 129 citations

Medicine, Pharmacology, Pharmacotherapy +14

<i>Helicobacter pylori</i> second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments

Javier P. Gisbert, Marco Romano, Antonietta Gerarda Gravina et al. · Alimentary Pharmacology & Therapeutics · 2015 · 107 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy

Javier P. Gisbert, Alicia C Marín, Adrián G. McNicholl · Digestive Diseases and Sciences · 2014 · 53 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +12

Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

Javier P. Gisbert, Ángeles Pérez‐Aísa, Luı́s Rodrigo et al. · Digestive Diseases and Sciences · 2013 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9